Literature DB >> 27018136

DC-STAMP: A Key Regulator in Osteoclast Differentiation.

Ya-Hui Chiu1, Christopher T Ritchlin1.   

Abstract

Osteoimmunology research is a new emerging research field that investigates the links between the bone and immune responses. Results from osteoimmunology studies suggest that bone is not only an essential component of the musculoskeletal system, but is also actively involved in immune regulation. Many important factors involved in immune regulation also participate in bone homeostasis. Bone homeostasis is achieved by a coordinated action between bone-synthesizing osteoblasts and bone-degrading osteoclasts. An imbalanced action between osteoblasts and osteoclasts often results in pathological bone diseases: osteoporosis is caused by an excessive osteoclast activity, whereas osteopetrosis results from an increased osteoblast activity. This review focuses on dendritic cell-specific transmembrane protein (DC-STAMP), an important protein currently considered as a master regulator of osteoclastogenesis. Of clinical relevance, the frequency of circulating DC-STAMP+ cells is elevated during the pathogenesis of psoriatic diseases. Intriguingly, recent results suggest that DC-STAMP also plays an imperative role in bone homeostasis by regulating the differentiation of both osteoclasts and osteoblasts. This article summarizes our current knowledge on DC-STAMP by focusing on its interacting proteins, its regulation on osteoclastogenesis-related genes, its possible involvement in immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated signaling cascade, and its potential of developing therapeutics for clinical applications. J. Cell. Physiol. 231: 2402-2407, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27018136      PMCID: PMC4946985          DOI: 10.1002/jcp.25389

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  78 in total

1.  The transient appearance of zipper-like actin superstructures during the fusion of osteoclasts.

Authors:  Jiro Takito; Masanori Nakamura; Masaki Yoda; Takahide Tohmonda; Shinichi Uchikawa; Keisuke Horiuchi; Yoshiaki Toyama; Kazuhiro Chiba
Journal:  J Cell Sci       Date:  2012-02-20       Impact factor: 5.285

2.  MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.

Authors:  Ce Dou; Chengcheng Zhang; Fei Kang; Xiaochao Yang; Hong Jiang; Yan Bai; Junyu Xiang; Jianzhong Xu; Shiwu Dong
Journal:  Biochim Biophys Acta       Date:  2014-08-11

3.  Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Ya-Hui Chiu; Kofi A Mensah; Edward M Schwarz; Yawen Ju; Masahiko Takahata; Changyong Feng; Loralee A McMahon; David G Hicks; Ben Panepento; Peter C Keng; Christopher T Ritchlin
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

4.  Mechanisms of osteoclast-dependent bone formation.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2013-12-04

Review 5.  Fracture non-union: Can biomarkers predict outcome?

Authors:  I Pountos; T Georgouli; S Pneumaticos; P V Giannoudis
Journal:  Injury       Date:  2013-09-13       Impact factor: 2.586

Review 6.  Advances in the regulation of osteoclasts and osteoclast functions.

Authors:  B F Boyce
Journal:  J Dent Res       Date:  2013-08-01       Impact factor: 6.116

7.  Transcription factor decoy against NFATc1 in human primary osteoblasts.

Authors:  Letizia Penolazzi; Gina Lisignoli; Elisabetta Lambertini; Elena Torreggiani; Cristina Manferdini; Andrea Lolli; Renata Vecchiatini; Francesca Ciardo; Elena Gabusi; Andrea Facchini; Roberto Gambari; Roberta Piva
Journal:  Int J Mol Med       Date:  2011-05-16       Impact factor: 4.101

8.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580

9.  RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.

Authors:  Susan Li; Christine H Miller; Eugenia Giannopoulou; Xiaoyu Hu; Lionel B Ivashkiv; Baohong Zhao
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 19.456

10.  Tibia shaft fractures: costly burden of nonunions.

Authors:  Evgeniya Antonova; T Kim Le; Russel Burge; John Mershon
Journal:  BMC Musculoskelet Disord       Date:  2013-01-26       Impact factor: 2.362

View more
  34 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

2.  A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and inflammatory bone destruction.

Authors:  Yanhui Tan; Wende Deng; Yueyang Zhang; Minhong Ke; Binhua Zou; Xiaowei Luo; Jianbin Su; Yiyuan Wang; Jialan Xu; Kutty Selva Nandakumar; Yonghong Liu; Xuefeng Zhou; Xiaojuan Li
Journal:  Br J Pharmacol       Date:  2020-08-11       Impact factor: 8.739

3.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

4.  Cell-surface phosphatidylserine regulates osteoclast precursor fusion.

Authors:  Santosh K Verma; Evgenia Leikina; Kamran Melikov; Claudia Gebert; Vardit Kram; Marian F Young; Berna Uygur; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

Review 5.  Extracellular vesicle-mediated bone metabolism in the bone microenvironment.

Authors:  Qi Li; Qiu-Ping Huang; Yi-Lin Wang; Qing-Sheng Huang
Journal:  J Bone Miner Metab       Date:  2017-08-01       Impact factor: 2.626

6.  Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.

Authors:  Ping Yang; Shan Lv; Yan Wang; Yi Peng; Zixing Ye; Zhuying Xia; Guoxian Ding; Xu Cao; Janet L Crane
Journal:  Bone       Date:  2018-05-23       Impact factor: 4.398

7.  Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.

Authors:  Anaïs Marie Julie Møller; Jean-Marie Delaissé; Jacob Bastholm Olesen; Jonna Skov Madsen; Luisa Matos Canto; Troels Bechmann; Silvia Regina Rogatto; Kent Søe
Journal:  Bone Res       Date:  2020-07-01       Impact factor: 13.567

8.  An SNX10-dependent mechanism downregulates fusion between mature osteoclasts.

Authors:  Maayan Barnea-Zohar; Sabina E Winograd-Katz; Moran Shalev; Esther Arman; Nina Reuven; Lee Roth; Ofra Golani; Merle Stein; Fadi Thalji; Moien Kanaan; Jan Tuckermann; Benjamin Geiger; Ari Elson
Journal:  J Cell Sci       Date:  2021-05-11       Impact factor: 5.285

9.  MicroRNAs are Critical Regulators of Osteoclast Differentiation.

Authors:  Henry C Hrdlicka; Sun-Kyeong Lee; Anne M Delany
Journal:  Curr Mol Biol Rep       Date:  2019-01-16

10.  Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression.

Authors:  Bin-Hua Zou; Yan-Hui Tan; Wen-de Deng; Jie-Huang Zheng; Qin Yang; Min-Hong Ke; Zong-Bao Ding; Xiao-Juan Li
Journal:  Acta Pharmacol Sin       Date:  2020-08-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.